Technical Analysis for PSTV - Plus Therapeutics, Inc.

Grade Last Price % Change Price Change
F 2.24 -3.86% -0.09
PSTV closed down 3.86 percent on Thursday, April 22, 2021, on 60 percent of normal volume.
Earnings due: Apr 22
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical PSTV trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Earnings Movers Other 0.00%
Slingshot Bearish Bearish Swing Setup -3.86%
Bullish Engulfing Bullish -3.86%
Crossed Above 20 DMA Bullish -3.86%
MACD Bullish Signal Line Cross Bullish -3.86%
Stochastic Buy Signal Bullish -3.86%
Pocket Pivot Bullish Swing Setup -3.86%
Wide Range Bar Range Expansion -3.86%
Lower Bollinger Band Touch Weakness -3.86%
Older End-of-Day Signals for PSTV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 5 hours ago
Fell Below 20 DMA about 5 hours ago
20 DMA Support about 9 hours ago
Rose Above Previous Day's High about 9 hours ago
Down 3% about 9 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Plus Therapeutics, Inc. Description

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and manufacture of treatments for cancer and other diseases. Its lead product candidate is DocePLUS, a protein-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer. The company is also involved in developing DoxoPLUS, a generic PEGylated liposomal encapsulated doxorubicin to treat breast and ovarian cancer, multiple myeloma, and Kaposi's sarcoma. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Clinical Medicine Pharmaceutical Diseases Drugs Small Cell Lung Cancer Ovarian Cancer Blastoma Stage Pharmaceutical Multiple Myeloma Glioblastoma Sarcoma Docetaxel Doxorubicin Eplus Pegylation Breast And Ovarian Cancer Chemotherapy Regimen

Is PSTV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.42
52 Week Low 1.4
Average Volume 1,152,135
200-Day Moving Average 2.50
50-Day Moving Average 2.69
20-Day Moving Average 2.25
10-Day Moving Average 2.14
Average True Range 0.22
ADX 13.75
+DI 25.00
-DI 18.44
Chandelier Exit (Long, 3 ATRs ) 2.72
Chandelier Exit (Short, 3 ATRs ) 2.59
Upper Bollinger Band 2.52
Lower Bollinger Band 1.98
Percent B (%b) 0.48
BandWidth 23.96
MACD Line -0.13
MACD Signal Line -0.15
MACD Histogram 0.018
Fundamentals Value
Market Cap 10.71 Million
Num Shares 4.78 Million
EPS -27.98
Price-to-Earnings (P/E) Ratio -0.08
Price-to-Sales 5.61
Price-to-Book 3.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.75
Resistance 3 (R3) 2.76 2.59 2.66
Resistance 2 (R2) 2.59 2.46 2.59 2.64
Resistance 1 (R1) 2.42 2.38 2.34 2.41 2.61
Pivot Point 2.25 2.25 2.21 2.25 2.25
Support 1 (S1) 2.08 2.12 2.00 2.07 1.87
Support 2 (S2) 1.91 2.04 1.91 1.84
Support 3 (S3) 1.74 1.91 1.82
Support 4 (S4) 1.73